ABVC BioPharma, Inc. (ABVC) Tops Q3 EPS by 38c

ABVC BioPharma, Inc. (NASDAQ: ABVC) reported Q3 EPS of ($0.02), $0.38 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $380 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on ABVC BioPharma, Inc. (ABVC) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Goldman Sachs says Fed rate hike unlikely in September
• NVIDIA (NVDA) call put ratio 1.9 calls to 1 put with a focus on 5K contracts of October 160 puts